de Luis D A, Aller R, Izaola O, Gonzalez Sagrado M, Conde R
Institute of Endocrinology and Nutrition, Medical School and Unit of Investigation, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain.
Nutr Hosp. 2010 Sep-Oct;25(5):730-5.
The aim of our study was to examine the changes in hypertransaminasemia after weight reduction in obese patients with and without NAFLD and the relation with insulin resistance.
A population of 162 obese patients was randomly allocated to two groups: a) diet I (low fat) and b) diet II (low carbohydrate), dieting along 3 months. Patients were classified as group I (n=112) when serum ALT activity was normal or group II (NAFLD, n=30) when serum ALT activity was (>or=43 UI/L).
In control group with diet I, BMI, weight, fat mass, waist to hip ratio, waist circumference, systolic pressure, total cholesterol, LDL cholesterol, HOMA and insulin levels decreased. In NAFLD group with diet I improved the same parameters and glucose, triglycerides, ALT, AST, gamaglutamine transferase levels, too. In control group with diet II, BMI, weight, fat mass, waist to hip ratio, waist circumference, systolic pressure, total cholesterol, LDL cholesterol, HOMA and insulin levels decreased. In NAFLD group with diet II improved the same parameters and glucose, triglycerides, ALT and gamaglutamine transferase levels, without statistical changes in AST.
We showed that weight reduction secondary to two hypocaloric diets was associated with improvement in hipertransaminasemia and insulin resistance in NAFLD patients.
我们研究的目的是检查非酒精性脂肪性肝病(NAFLD)患者和非NAFLD肥胖患者体重减轻后高转氨酶血症的变化及其与胰岛素抵抗的关系。
162名肥胖患者被随机分为两组:a)饮食I(低脂)和b)饮食II(低碳水化合物),节食3个月。血清丙氨酸氨基转移酶(ALT)活性正常时患者被分类为I组(n = 112),血清ALT活性(≥43 UI/L)时患者被分类为II组(NAFLD,n = 30)。
在采用饮食I的对照组中,体重指数(BMI)、体重、脂肪量、腰臀比、腰围、收缩压、总胆固醇、低密度脂蛋白胆固醇、稳态模型评估胰岛素抵抗指数(HOMA)和胰岛素水平下降。在采用饮食I的NAFLD组中,相同参数以及血糖、甘油三酯、ALT、天冬氨酸氨基转移酶(AST)、γ-谷氨酰转移酶水平也得到改善。在采用饮食II的对照组中,BMI、体重、脂肪量、腰臀比、腰围、收缩压、总胆固醇、低密度脂蛋白胆固醇、HOMA和胰岛素水平下降。在采用饮食II的NAFLD组中,相同参数以及血糖、甘油三酯、ALT和γ-谷氨酰转移酶水平得到改善,AST无统计学变化。
我们表明,两种低热量饮食导致的体重减轻与NAFLD患者高转氨酶血症和胰岛素抵抗的改善有关。